TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NOVEL PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

NOVEL PHARMA

ST13

US500000097155447

Class

42

Filing

97155447

Registration

7484319

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

08/27/2024

Classification

Registered

Trademark type

Word

Nice classes

42

Filing date

12/03/2021

Registration date

08/27/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/27/2024

Last transaction

08/27/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Gangnam-gu, Seoul, KR

Examiner

MAYES, LAURIE ANN

Law office

L10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Novel Pharma Inc.

Representatives

Alexander J. Kim GREENBERG TRAURIG, LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Technical consultancy relating to research services in the field of foods and dietary supplements; Scientific research in the fields of biomedicine; Research and testing services in the fields of bacteriology and virology; Drug discovery services; Scientific research for medical purposes in the area of cancerous diseases; Development of pharmaceutical preparations and medicines; Medical research laboratory services; Medical research; Providing information on the testing and research of medical products; Providing information on the inspection of medical products for quality control purposes; Providing scientific consultation and scientific information in the fields of medicine, health and pharmacology; Scientific research in the nature of conducting clinical trials for others; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Genetic testing for scientific research purposes; Research and development of vaccines and medicines; Research and development of technology for biotechnology; Advisory services relating to biotechnology; Scientific research in the field of genetics and genetic engineering; Laboratory research in the field of chemistry; Research and development of medical apparatus and instruments for others; Research and development of medical equipment

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/27/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/27/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/11/2024

PUBO

PUBLISHED FOR OPPOSITION

06/11/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/22/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/18/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/18/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/18/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

01/19/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

01/19/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/20/2023

GNFR

FINAL REFUSAL E-MAILED

10/20/2023

CNFR

FINAL REFUSAL WRITTEN

10/20/2023

NREV

NOTICE OF REVIVAL - E-MAILED

06/06/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/05/2023

PETG

PETITION TO REVIVE-GRANTED

06/05/2023

PROA

TEAS PETITION TO REVIVE RECEIVED

06/05/2023

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

04/03/2023

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

04/03/2023

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

04/03/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/15/2022

GNRT

NON-FINAL ACTION E-MAILED

09/15/2022

CNRT

NON-FINAL ACTION WRITTEN

09/15/2022

DOCK

ASSIGNED TO EXAMINER

09/13/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/07/2021

NWAP

NEW APPLICATION ENTERED

12/07/2021

Continuous trademark protection

Get notified about every new filing that threatens NOVEL PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.